Scott Dryden-Peterson

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. pmc Increased risk of severe infant anemia after exposure to maternal HAART, Botswana
    Scott Dryden-Peterson
    Department of Medicine, Division of Infectious Diseases, Brigham and Women s Hospital, Boston, MA 02115, USA
    J Acquir Immune Defic Syndr 56:428-36. 2011
  2. pmc Highly active antiretroviral therapy versus zidovudine for prevention of mother-to-child transmission in a programmatic setting, Botswana
    Scott Dryden-Peterson
    Department of Medicine, Division of Infectious Diseases, Brigham and Women s Hospital, Boston, MA 02115, USA
    J Acquir Immune Defic Syndr 58:353-7. 2011
  3. pmc Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana
    Kathleen M Powis
    Department of Internal Medicine and Pediatrics, Massachusetts General Hospital, Boston, MA, USA
    J Acquir Immune Defic Syndr 56:131-8. 2011
  4. pmc Cotrimoxazole prophylaxis and risk of severe anemia or severe neutropenia in HAART-exposed, HIV-uninfected infants
    Scott Dryden-Peterson
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts, United States of America Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS ONE 8:e74171. 2013
  5. ncbi request reprint Risk factors for mortality among human immunodeficiency virus-exposed and unexposed infants admitted to a neonatal intensive care unit in Botswana
    Rebecca M Zash
    Division of Infectious Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States Botswana Harvard AIDS Institute Partnership for HIV Research and Education, Gaborone, Botswana
    J Paediatr Child Health 50:189-95. 2014
  6. pmc Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana
    Jennifer Y Chen
    Department of Medicine, Brigham and Women s Hospital, Berlin, Germany
    J Infect Dis 206:1695-705. 2012
  7. doi request reprint Antiretroviral treatment initiation among HIV-infected pregnant women with low CD4(+) cell counts in Gaborone, Botswana
    Jennifer Y Chen
    Harvard Medical School, Boston, MA, USA
    J Acquir Immune Defic Syndr 54:102-6. 2010
  8. pmc Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study
    Edward C Jones-Lopez
    Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston University Medical School, Boston, Massachusetts, USA
    PLoS Med 8:e1000427. 2011

Collaborators

Detail Information

Publications8

  1. pmc Increased risk of severe infant anemia after exposure to maternal HAART, Botswana
    Scott Dryden-Peterson
    Department of Medicine, Division of Infectious Diseases, Brigham and Women s Hospital, Boston, MA 02115, USA
    J Acquir Immune Defic Syndr 56:428-36. 2011
    ..Maternal highly-active antiretroviral therapy (HAART) reduces mother-to-child HIV transmission but may increase the risk for infant anemia...
  2. pmc Highly active antiretroviral therapy versus zidovudine for prevention of mother-to-child transmission in a programmatic setting, Botswana
    Scott Dryden-Peterson
    Department of Medicine, Division of Infectious Diseases, Brigham and Women s Hospital, Boston, MA 02115, USA
    J Acquir Immune Defic Syndr 58:353-7. 2011
    ..Maternal HAART was associated with decreased prevention of mother-to-child transmission (P = 0.001) and improved HIV-free survival (P = 0.040) compared with zidovudine (with or without single-dose nevirapine) in a programmatic setting...
  3. pmc Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana
    Kathleen M Powis
    Department of Internal Medicine and Pediatrics, Massachusetts General Hospital, Boston, MA, USA
    J Acquir Immune Defic Syndr 56:131-8. 2011
    ..The impact of in utero exposure to highly active antiretroviral therapy (HAART) on longitudinal growth of HIV-uninfected infants is unknown...
  4. pmc Cotrimoxazole prophylaxis and risk of severe anemia or severe neutropenia in HAART-exposed, HIV-uninfected infants
    Scott Dryden-Peterson
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts, United States of America Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS ONE 8:e74171. 2013
    ..Prophylactic cotrimoxazole is recommended for infants born to HIV-infected mothers. However, cotrimoxazole may increase the risk of severe anemia or neutropenia...
  5. ncbi request reprint Risk factors for mortality among human immunodeficiency virus-exposed and unexposed infants admitted to a neonatal intensive care unit in Botswana
    Rebecca M Zash
    Division of Infectious Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States Botswana Harvard AIDS Institute Partnership for HIV Research and Education, Gaborone, Botswana
    J Paediatr Child Health 50:189-95. 2014
    ..We describe risk factors for NNU mortality in an area with high prevalence of human immunodeficiency virus (HIV)...
  6. pmc Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana
    Jennifer Y Chen
    Department of Medicine, Brigham and Women s Hospital, Berlin, Germany
    J Infect Dis 206:1695-705. 2012
    ..It is unknown whether adverse birth outcomes are associated with maternal highly active antiretroviral therapy (HAART) in pregnancy, particularly in resource-limited settings...
  7. doi request reprint Antiretroviral treatment initiation among HIV-infected pregnant women with low CD4(+) cell counts in Gaborone, Botswana
    Jennifer Y Chen
    Harvard Medical School, Boston, MA, USA
    J Acquir Immune Defic Syndr 54:102-6. 2010
    ..We analyzed rates of HIV testing, CD4 cell count testing, and HAART initiation during pregnancy...
  8. pmc Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study
    Edward C Jones-Lopez
    Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston University Medical School, Boston, Massachusetts, USA
    PLoS Med 8:e1000427. 2011
    ..The effectiveness of this retreatment regimen has not been systematically evaluated...